Stock OASM OASMIA PHARMACEUTICAL AB
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Oasmia Pharmaceutical AB NORDIC GROWTH MARKET

Equities

OASM

SE0000722365

Pharmaceuticals

Business Summary

Vivesto AB, formerly Oasmia Pharmaceutical AB is a Swecen-based pharma company that develops new treatment options for patients suffering from difficult-to-treat cancer. The company has a growing portfolio of projects in the clinical phase focused on advanced cancer. Apealea (paclitaxel micellar) is being developed for patients with ovarian cancer through a partnership with Elevar Therapeutics, Inc. Other development programs include Cantrixil, a clinical program in advanced ovarian cancer, and docetaxel micellar, which is being developed for widespread prostate cancer. Vivesto's patented technology platform is developed to improve the water solubility, efficacy and safety of drugs.

Sales per region

SEK in Million2021Weight2022Weight Delta
European Union
100.0 %
-- 1 100.0 % -

Managers

Managers TitleAgeSince
Erik Kinnman CEO
 Chief Executive Officer 66 23-01-22
Robert Maiorana DFI
 Director of Finance/CFO 64 20-11-30
Heidi Ramstad CTO
 Chief Tech/Sci/R&D Officer 55 21-02-28
Johanna Röstin LAW
 General Counsel 57 21-09-30

Members of the board

Members of the board TitleAgeSince
Isak Peter Zonabend CHM
 Chairman 44 19-03-18
Hege Hellstrom BRD
 Director/Board Member 59 19-09-25
Pål Ryfors BRD
 Director/Board Member 41 22-05-24
Roger Tell BRD
 Director/Board Member 59 22-05-24

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 538,043,000 329,854,634 ( 61.31 %) 0 61.31 %

Shareholders

NameEquities%Valuation
FCG Fonder AB
0.2486 %
1,337,443 0.2486 % 34 185 kr
Storebrand Asset Management AS
0.0817 %
439,703 0.0817 % 11 239 kr
Evli Fund Management Co. Ltd.
0.005326 %
28,656 0.005326 % 732 kr

Company contact information

Vivesto AB

P. O. Box 3061

169 03, Solna

+46 18 50 54 40

http://www.oasmia.com
address Oasmia Pharmaceutical AB(OASM)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+45.82% 765B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+40.95% 632B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.16% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.86% 331B
ABBVIE INC. Stock AbbVie Inc.
+9.32% 299B
ASTRAZENECA PLC Stock AstraZeneca PLC
+18.45% 248B
ROCHE HOLDING AG Stock Roche Holding AG
-0.78% 219B
NOVARTIS AG Stock Novartis AG
+11.88% 216B
AMGEN INC. Stock Amgen Inc.
+5.90% 164B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. VIVE Stock
  4. OASM Stock
  5. Company Oasmia Pharmaceutical AB